Affinity Sues Ameritrade for Patent Infringement.

Business Editors

COLUMBIA, S.C.--(BUSINESS WIRE)--Sept. 2, 2003

Affinity Technology Group, Inc. (OTCBB:AFFI) today announced that its patent licensing subsidiary, decisioning.com, Inc., has filed a complaint in the United States District Court in Columbia, South Carolina against Ameritrade Holding Corporation, Inc. and its subsidiary, Ameritrade, Inc. In the complaint, decisioning.com alleges that Ameritrade's "Express Application" feature, which allows applicants to open and fund accounts online, infringes one of the Company's patents (U. S. Patent No. 6,105,007).

Affinity also announced that it has completed a private placement of $50,000 principal amount of its convertible notes. Of such amount, $25,000 was funded immediately, and the remaining $25,000 will be funded in January 2004. The convertible notes were issued under the Company's convertible note program. The notes mature two years after funding, are convertible into the Company's stock at $0.20 per share, and are secured by all the outstanding stock of the Company's wholly-owned patent licensing subsidiary, decisioning.com.

About Affinity Technology Group, Inc.

Through its subsidiary, decisioning.com, Inc., Affinity Technology Group, Inc., owns a portfolio of patents that cover the automated processing and establishment of loans, financial accounts and credit accounts through an applicant-directed remote interface, such as a personal computer or terminal touch screen. Affinity's patent portfolio includes U. S. Patent No. 5,870,721, No. 5,940,811, and No. 6,105,007.

Forward-looking statements in this news release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We cannot assure investors we will prevail in whole or in part in the lawsuit described in this news release or that this lawsuit will result in an opportunity to generate meaningful revenue from any of our patents. Moreover, our patents may be subject to additional reexamination by the U. S. Patent and Trademark Office or additional challenges by third parties, and we may lose all or part of the claims covered by these patents. Further, our financial position and future operating results may be materially affected by the outcome of ongoing litigation against us by a plaintiff who claims that he was promised a 1% equity interest in the Company for services he claims to have performed in 1993 and 1994. In addition, we may not have sufficient capital resources to execute our patent licensing strategy, continue our operations, or prosecute or defend ourselves in pending litigation involving the Company. Investors are cautioned that these forward-looking statements involve these and other risks and uncertainties that may cause actual results to differ materially from those projected.